Skip to main content
logo
Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.350
+0.020 (0.60%)
At close: Jul 6, 2026, 4:00 PM EDT
3.340
-0.010 (-0.30%)
After-hours: Jul 6, 2026, 4:10 PM EDT

Lisata Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.170.171---
Revenue Growth (YoY)
--83.00%----
Gross Profit
0.170.171---
Selling, General & Admin
10.9210.4312.0812.9714.1411.47
Research & Development
6.557.9511.3312.7343.4617.58
Total Operating Expenses
17.4718.3823.4125.7157.629.05
Operating Income
-17.3-18.21-22.41-25.71-57.6-29.05
Interest Income
0.660.811.882.721.050.15
Other Non-Operating Income (Expense)
-0.08-0.15-0.26-0.19-0.16-0.08
Total Non-Operating Income (Expense)
0.580.661.632.540.90.08
Pretax Income
-16.72-17.55-20.78-23.17-56.7-28.97
Provision for Income Taxes
-0.39-0.96-0.8-2.33-2.48-1.51
Net Income
-16.35-16.59-19.99-20.84-54.23-27.47
Net Income to Common
-16.35-16.59-19.99-20.84-54.23-27.47
Shares Outstanding (Basic)
998854
Shares Outstanding (Diluted)
998854
Shares Change (YoY)
4.53%4.30%3.17%55.85%40.46%258.29%
EPS (Basic)
-1.86-1.91-2.40-2.58-10.47-7.45
EPS (Diluted)
-1.86-1.91-2.40-2.58-10.47-7.45
Free Cash Flow
-13.63-15.98-19.36-20.03-21.46-22.31
Free Cash Flow Per Share
-1.55-1.84-2.32-2.48-4.14-6.05
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-10178.20%-10711.20%-2240.90%---
Profit Margin
-9618.24%-9756.47%-1998.50%---
FCF Margin
-8017.65%-9398.24%-1935.60%---
EBITDA
-17.2-18.06-22.24-25.52-57.53-29
EBITDA Margin
-10116.50%-10625.30%-2223.50%---
EBIT
-17.3-18.21-22.41-25.71-57.6-29.05
EBIT Margin
-10178.20%-10711.20%-2240.90%---
Effective Tax Rate
2.31%5.48%3.84%10.06%4.37%5.20%
SEC Filings: 10-K · 10-Q